A randomised control trial of two different speech therapy approaches (Rapid Syllable Transition Treatment and Nuffield Dyspraxia Programme 3rd edition) to treating Childhood Apraxia of Speech.

Not Applicable

Active, not recruiting

• Conditions: Childhood Apraxia of Speech; Neurological - Other neurological disorders; Physical Medicine / Rehabilitation - Speech therapy

• Registration Number: ACTRN12612000744853
• Lead Sponsor: Elizabeth Murray

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-07-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

a) clinical diagnosis of suspected Childhood Apraxia of Speech (CAS),
b) between 4 and 12 years of age,
c) comprehension skills within 1 SD of the mean for a child’s chronological age (based on normative data for the receptive language score from the Clinical Evaluation of Language Fundamentals (CELF) - Fourth edition or CELF Preschool - Second edition (Semel et al, 2006),
d) normal or adjusted-to-normal hearing and vision,
e) the child and at least one parent as native Australian English speakers, and
f) no other diagnosed developmental / genetic disorders.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified